his best bet is

来源: jaydad 于 2013-01-13 20:27:55 [档案] [博客] [旧帖] [给我悄悄话] 本文已被阅读：次 (298 bytes)

回答: 急性淋巴细胞性白血病请教由 xinxinren 于 2013-01-13 15:24:34

ponatinib, or Iclusig, formally known as AP24534 in clinical trials, made by a Boston-based company Ariad Pharmaceuticals, Inc.

Iclusig was approved by FDA about a month ago, for treatment of AML and Ph+ ALL that can no longer be controlled by Gleevac and chemotherapies.

您的位置：文学城 » 论坛 » 健康养生 » his best bet is

• should also mention -jaydad- ♂ (434 bytes) () 01/13/2013 postreply 21:14:13

• Thank you so much, that is good news! but -xinxinren- ♀ (90 bytes) () 01/14/2013 postreply 11:50:24

发现Adblock插件